The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19.
Fabiana FurciMarco CaminatiGianenrico SennaSebastiano GangemiPublished in: Clinical and molecular allergy : CMA (2021)
The hypothesis that corticosteroids, commonly used in treating airways diseases, might modify the severity of SARS-CoV-2 disease has become a key point and a possible predictive factor of a positive outcome of COVID-19 in patients treated everyday with these molecules.